Allergy Vaccine Current Events | Allergy Vaccine News
|
| Page
1 of
40 |
792 Results |
|
|
|
Sort By:
Page Views | Date |
New survey shows allergies dramatically impact sufferers' moods and how they feel about themselves
A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer's mood and self-perceptions. view more (2008-03-20)
Progress made on group B streptococcus vaccine
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. view more (2009-11-02)
Ebola DNA vaccine produces immune responses in all fully vaccinated volunteers in Phase 1 trial
Vical Incorporated (Nasdaq:VICL) announced today that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine. view more (2006-02-22)
Combating anthrax: Results of study published this month as researchers look for a better vaccine
A new study published this month by a Saint Louis University vaccine researcher scrutinizes what in the future could be an alternative to the presently available anthrax vaccine. view more (2006-08-15)
New allergy vaccine provides long-lasting hay fever relief after just 6 weeks of shots
Researchers at The Johns Hopkins University School of Medicine have successfully used an experimental DNA-based vaccine to protect against ragweed allergies, commonly known as hay fever, after just six injections. view more (2006-10-05)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
STEP HIV vaccine study to be unblinded
Merck & Co., Inc. and the HIV Vaccine Trials Network (HVTN) today announced that study volunteers in the STEP study of Merck's HIV vaccine (V520) will be told whether they received vaccine or placebo, and all study volunteers will be encouraged to continue to return to their study sites on a regular basis for ongoing risk reduction counseling... view more... (2007-11-14)
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine to Conduct Innovative Smallpox Vaccine Research Study
University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease. view more (2007-06-04)
Early promising results in malaria vaccine trial in Mali
A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it. view more (2008-01-23)
NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
Most vaccines that protect against viruses generate infection-fighting proteins called antibodies that either block infection or help eliminate the virus before it can cause disease. view more (2009-06-15)
Volunteers sought for avian flu vaccine study
Vanderbilt University Medical Center is enrolling volunteers in a study to test a new vaccine that targets avian flu, the first such vaccine against the virus. view more (2005-10-31)
Study reveals dramatic rise in allergic diseases
Dramatic increases in admissions to hospital for allergic diseases have occurred in England over the last decade, finds a study in this week's BMJ. Researchers in London used national hospital discharge statistics from 1990-1 to 2000-1 to identify trends in admissions for four allergic conditions (anaphylaxis, angio-oedema, food allergy, and... view more... (2003-11-11)
LIAI Researchers Discover New Cellular Mechanism That Will Significantly Advance Vaccine Development
La Jolla Institute for Allergy & Immunology (LIAI) scientists have discovered one for the textbooks. Their finding, reported Friday in the scientific journal Immunity, illuminates a new, previously unknown mechanism in how the body fights a virus. view more (2008-06-17)
Duke To Test Bird Flu Vaccine Dosing
A clinical trial to test different strengths of a vaccine designed to fight avian influenza will begin this month at Duke University Medical Center. view more (2006-03-31)
Universal flu vaccine holds promise
An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found. view more (2009-04-28)
Producing flu vaccines will be faster and cheaper, thanks to MSU technology
Technology from Michigan State animal science labs looks to produce new human flu vaccines quicker and cheaper than current methods. view more (2006-07-12)
Perth researchers to trial bird flu vaccine
Perth researchers have begun a trial to test the effectiveness of a new vaccine to protect against the potentially deadly bird flu. view more (2006-06-29)
How HIV vaccine might have increased odds of infection
In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection. view more (2008-11-03)
An HIV Vaccine is within reach
An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week's BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships. view more (2002-01-23)
Acellular pertussis vaccine proves effective in adults, adolescents
A vaccine to protect adults and adolescents against illness due to Bordetella pertussis infection-or whooping cough-has proved more than 90 percent effective in a national, large-scale clinical study. view more (2005-10-13)
|
|
| Page
1 of
40 |
792 Results |
|
|
|
Sort By:
Page Views | Date |
|
